Abstract
The glucuronyl C5-epimerase is a key enzyme in the biosynthesis of heparan sulfate (HS) and heparin, a group of polysaccharide composed of alternating hexuronic acid and glucosamine residues. Both species are synthesized as proteoglycans, but on different core proteins (Esko 1991). Heparin is essentially only expressed by connective-tissue-type mast cells, whereas HS is produced by all other mammalian (and many nonmammalian) cells. The process of HS and heparin biosynthesis is initiated by glycosylation of the core proteins through covalently binding to the serine residues in respective core proteins. The process generates polysaccharide sequences that are composed of alternating d-glucuronic acid (GlcA) and N-acetyl-d-glucosamine (GlcNAc) units with varied chain length. The resulting polymer of (GlcAß1,4-GlcNAca1,4)n disaccharide repeats is modified through a series of reactions, including N-deacetylation/N-sulfation of GlcNAc residues, C5-epimerization of the GlcA units to yield l-iduronic acid (IdoA) residues, and finally O-sulfation at various positions of the sugar residues (Lindahl and Li 2009). The modification reactions occur in a stepwise manner, such that early steps provide the substrates for subsequent reactions. Heparin is extensively sulfated and has a high content of IdoA (typically 50–90 % of the total hexuronic acid), whereas HS has a more varied structure, generally less sulfated and with lower IdoA content than heparin (typically 30–55 % of the total hexuronic acid) (Taylor et al. 1973).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Babu P, Victor XV, Nelsen E, Nguyen TK, Raman K, Kuberan B (2011) Hydrogen/deuterium exchange-LC-MS approach to characterize the action of heparan sulfate C5-epimerase. Anal Bioanal Chem 401(1):237–244
Bishop JR, Schuksz M, Esko JD (2007) Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature 446(7139):1030–1037
Bulow HE, Hobert O (2004) Differential sulfations and epimerization define heparan sulfate specificity in nervous system development. Neuron 41(5):723–736
Campbell P, Feingold DS, Jensen JW, Malmström A, Rodén L (1983) New assay for uronosyl 5-Epimerases. Anal Biochem 131:146–152
Campbell P, Hannesson HH, Sandbäck D, Rodén L, Lindahl U, Li J-P (1994) Biosynthesis of heparin/heparan sulfate. Purification of the D-glucuronyl C-5 epimerase from bovine liver. J Biol Chem 269(43):26953–26958
Casu B, Petitou M, Provasoli M, Sinay P (1988) Conformational flexibility: a new concept for explaining binding and biological properties of iduronic acid-containing glycosaminoglycans. Trends Biochem Sci 13(6):221–225
Crawford BE, Olson SK, Esko JD, Pinhal MA (2001) Cloning, Golgi localization, and enzyme activity of the full-length heparin/heparan sulfate-glucuronic acid C5-epimerase. J Biol Chem 276(24):21538–21543
Esko JD (1991) Genetic analysis of proteoglycan structure, function and metabolism. Curr Opin Cell Biol 3:805–816
Gallagher JT (2001) Heparan sulfate: growth control with a restricted sequence menu. J Clin Invest 108(3):357–361
Ghiselli G, Farber SA (2005) D-glucuronyl C5-epimerase acts in dorso-ventral axis formation in zebrafish. BMC Dev Biol 5:19
Gong F, Jemth P, Escobar Galvis ML, Vlodavsky I, Horner A, Lindahl U, Li JP (2003) Processing of macromolecular heparin by heparanase. J Biol Chem 278(37):35152–35158
Gray E, Mulloy B, Barrowcliffe TW (2008) Heparin and low-molecular-weight heparin. Thromb Haemost 99(5):807–818
Grigorieva E, Eshchenko T, Rykova VI, Chernakov A, Zabarovsky E, Sidorov SV (2008) Decreased expression of human D-glucuronyl C5-epimerase in breast cancer. Int J Cancer 122(5):1172–1176
Grigorieva EV, Prudnikova TY, Domanitskaya NV, Mostovich LA, Pavlova TV, Kashuba VI, Zabarovsky ER (2011) D-glucuronyl C5-epimerase suppresses small-cell lung cancer cell proliferation in vitro and tumour growth in vivo. Br J Cancer 105(1):74–82
Hagner-McWhirter A, Hannesson HH, Campbell P, Westley J, Roden L, Lindahl U, Li J-P (2000a) Biosynthesis of heparin/heparan sulfate: kinetic studies of the glucuronyl C5-epimerase with N-sulfated derivatives of the escherichia coli K5 capsular polysaccharide as substrates. Glycobiology 10(2):159–171. [In Process Citation]
Hagner-Mcwhirter A, Lindahl U, Li J-P (2000b) Biosynthesis of heparin/heparan sulphate: mechanism of epimerization of glucuronyl C-5. Biochem J 347:69–75
Hagner-McWhirter A, Li JP, Oscarson S, Lindahl U (2004) Irreversible glucuronyl C5-epimerization in the biosynthesis of heparan sulfate. J Biol Chem 279(15):14631–14638
Höök M, Lindahl U, Backstrom G, Malmstrom A, Fransson L (1974) Biosynthesis of heparin. 3. Formation of iduronic acid residues. J Biol Chem 249(12):3908–3915
Jacobsson I, Bäckström G, Höök M, Lindahl U, Feingold DS, Malmström A, Rodén L (1979) Biosynthesis of heparin. Assay and properties of the microsomal uronosyl C-5 epimerase. J Biol Chem 254(8):2975–2982
Jacobsson I, Lindahl U, Jensen JW, Rodén L, Prihar H, Feingold DS (1984) Biosynthesis of heparin. Substrate specificity of heparosan N-sulfate d-glucuronosyl 5-epimerase. J Biol Chem 259:1056–1063
Jia J, Maccarana M, Zhang X, Bespalov M, Lindahl U, Li JP (2009) Lack of l-iduronic acid in heparan sulfate affects interaction with growth factors and cell signaling. J Biol Chem 284(23):15942–15950
Kuberan B, Lech MZ, Beeler DL, Wu ZL, Rosenberg RD (2003) Enzymatic synthesis of antithrombin III-binding heparan sulfate pentasaccharide. Nat Biotechnol 21(11):1343–1346
Lander AD, Selleck SB (2000) The elusive functions of proteoglycans: in vivo veritas. J Cell Biol 148(2):227–232
Li JP (2010) Glucuronyl C5-epimerase an enzyme converting glucuronic acid to iduronic acid in heparan sulfate/heparin biosynthesis. Prog Mol Biol Transl Sci 93:59–78
Li J-P, Hagner-McWhirter A, Kjellen L, Palgi J, Jalkanen M, Lindahl U (1997) Biosynthesis of heparin/heparan sulfate. cDNA cloning and expression of D-glucuronyl C5-epimerase from bovine lung. J Biol Chem 272(44):28158–28163
Li JP, Gong F, El Darwish K, Jalkanen M, Lindahl U (2001) Characterization of the D-glucuronyl C5-epimerase involved in the biosynthesis of heparin and heparan sulfate. J Biol Chem 276(23):20069–20077
Li J-P, Gong F, Hagner-McWhirter Å, Forsberg E, Åbrink M, Kisilevsky R, Zhang X, Lindahl U (2003) Targeted disruption of a murine glucuronyl C5-epimerase gene results in heparan sulfate lacking L-iduronic acid and in neonatal lethality. J Biol Chem 278(31):28363–28366
Lindahl U, Li J-P (2009) Interactions between heparan sulfate and proteins – design and functional implications. Int Rev Cell Mol Biol 276(27603):105–159
Lindahl U, Kusche-Gullberg M, Kjellén L (1998) Regulated diversity of heparan sulfate. J Biol Chem 273(39):24979–24982
Lindahl U, Li JP, Kusche-Gullberg M, Salmivirta M, Alaranta S, Veromaa T, Emeis J, Roberts I, Taylor C, Oreste P, Zoppetti G, Naggi A, Torri G, Casu B (2005) Generation of “neoheparin” from E. coli K5 capsular polysaccharide. J Med Chem 48(2):349–352
Maccarana M, Sakura Y, Tawada A, Yoshida K, Lindahl U (1996) Domain structure of heparan sulfates from bovine organs. J Biol Chem 271(30):17804–17810
Maccarana M, Olander B, Malmstrom J, Tiedemann K, Aebersold R, Lindahl U, Li JP, Malmstrom A (2006) Biosynthesis of dermatan sulfate: chondroitin-glucuronate C5-epimerase is identical to SART2. J Biol Chem 281(17):11560–11568
Malmström A, Åberg L (1982) Biosynthesis of dermatan sulfate: assay and properties of the uronyl C-5 epimerase. Biochem J 201:489–493
Malmstrom A, Roden L, Feingold DS, Jacobsson I, Backstrom G, Lindahl U (1980) Biosynthesis of heparin. Partial purification of the uronosyl C-5 epimerase. J Biol Chem 255(9):3878–3883
Mostovich LA, Prudnikova TY, Kondratov AG, Gubanova NV, Kharchenko OA, Kutsenko OS, Vavilov PV, Haraldson K, Kashuba VI, Ernberg I, Zabarovsky ER, Grigorieva EV (2012) The TCF4/beta-catenin pathway and chromatin structure cooperate to regulate D-glucuronyl C5-epimerase expression in breast cancer. Epigenetics 7(8):930–939
Nader HB, Chavante SF, dos-Santos EA, Oliveira TW, de-Paiva JF, Jeronimo SM, Medeiros GF, de-Abreu LR, Leite EL, de-Sousa-Filho JF, Castro RA, Toma L, Tersariol IL, Porcionatto MA, Dietrich CP (1999) Heparan sulfates and heparins: similar compounds performing the same functions in vertebrates and invertebrates? Braz J Med Biol Res 32(5):529–538
Peterson S, Frick A, Liu J (2009) Design of biologically active heparan sulfate and heparin using an enzyme-based approach. Nat Prod Rep 26(5):610–627
Prihar HS, Campbell P, Feingold DS, Jacobsson I, Jensen JW, Lindahl U, Rodén L (1980) Biosynthesis of heparin. Hydrogen exchange at carbon 5 of the glycuronosyl residues. Biochemistry 19:495–500
Salmivirta M, Lidholt K, Lindahl U (1996) Heparan sulfate: a piece of information. FASEB J 10(11):1270–1279
Sheng J, Xu Y, Dulaney SB, Huang X, Liu J (2012) Uncovering biphasic catalytic mode of C5-epimerase in heparan sulfate biosynthesis. J Biol Chem 287(25):20996–21002
Smits NC, Kurup S, Rops AL, ten Dam GB, Massuger LF, Hafmans T, Turnbull JE, Spillmann D, Li JP, Kennel SJ, Wall JS, Shworak NW, Dekhuijzen PN, van der Vlag J, van Kuppevelt TH (2010) The heparan sulfate motif (GlcNS6S-IdoA2S)3, common in heparin, has a strict topography and is involved in cell behavior and disease. J Biol Chem 285(52):41143–41151
Taylor RL, Shively JE, Cifonelli JA (1973) Uronic acid composition of heparins and heparan sulfates. Biochemistry 12:3633–3637
Valla S, Li J, Ertesvag H, Barbeyron T, Lindahl U (2001) Hexuronyl C5-epimerases in alginate and glycosaminoglycan biosynthesis. Biochimie 83(8):819–830
Xu Y, Pempe EH, Liu J (2012) Chemoenzymatic synthesis of heparin oligosaccharides with both anti-factor Xa and anti-factor IIa activities. J Biol Chem 287(34):29054–29061
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Japan
About this entry
Cite this entry
Li, Jp. (2014). Heparin-Heparansulfate Related GlcA C5-Epimerase. In: Taniguchi, N., Honke, K., Fukuda, M., Narimatsu, H., Yamaguchi, Y., Angata, T. (eds) Handbook of Glycosyltransferases and Related Genes. Springer, Tokyo. https://doi.org/10.1007/978-4-431-54240-7_157
Download citation
DOI: https://doi.org/10.1007/978-4-431-54240-7_157
Published:
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-54239-1
Online ISBN: 978-4-431-54240-7
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences